Aphria Inc. (NYSE:APHA) is now up 79.73% compared to a 12-month low of $3.75. We have seen the price to move -1.03% lower and get settled at $6.74 on 6/19/2019. At recent session, it appeared stuck in a range of $6.72 to $6.91. This company shares are -100% up from its target price of $0 and the current market capitalization stands at $1.68B. The recent change has given its price a -9.34% deficit over SMA 50 and -60.02% deficit over its 52-week high. The stock witnessed 1.66% gains, -33.4% declines and 24.13% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found APHA’s volatility during a week at 3.48% and during a month it has been found around 5.2%.

What Does Aphria Inc. (APHA) Do?

The company describes itself in regulatory filings as, “Aphria, Inc. engages in the production and supply of medical cannabis. Its products include cannabis capsules, oral solutions, concentrate syringes and tetrahydrocannabinol and cannabidiol vaporizers. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada.” [Text can be found here: https://www.marketwatch.com/investing/stock/APHA/profile under company description.]

Aphria Inc. (APHA) Top Holders

Institutional investors currently hold around $156 million or 15.24% in APHA stock. Look at its top three institutional owners: Vanguard Group Inc owns $35.87 million in Aphria Inc., which represents roughly 2.13% of the company’s market cap and approximately 22.99% of the institutional ownership. Similar statistics are true for the second largest owner, Morgan Stanley, which owns 4,943,889 shares of the stock are valued at $33.67 million. The third largest holder is Manufacturers Life Insurance Company, The, which currently holds $18.98 million worth of this stock and that ownership represents nearly 1.13% of its market capitalization.

Aphria Inc. 13F Filings

At the end of March reporting period, 99 institutional holders increased their position in Aphria Inc. (NYSE:APHA) by some 5,644,132 shares, 43 decreased positions by 6,838,008 and 47 held positions by 10,468,451. That puts total institutional holdings at 22,950,591 shares, according to SEC filings. The stock grabbed 55 new institutional investments totaling 3,633,653 shares while 24 institutional investors sold out their entire positions totaling 2,813,093 shares.

Aphria Inc. (APHA) Analyst Guide

Several analysts have released their opinion on Aphria Inc. (NYSE:APHA), with 4 analysts believing it is a strong buy. Whereas 3 of them predict the stock is a hold. Also, there are 5 buy, 1 sell and 0 strong sell ratings, collectively assigning a 2.08 average brokerage recommendation [T1].